Expect Pharmaceuticals M&A Activity to Rebound After COVID-19 Eases
April 17, 2020 at 12:23 PM EDT
The pharmaceutical industry is often a hotbed of takeover rumors. Some experts believe that speculation and deals themselves could heat up again after the coronavirus outbreak subsides, potentially benefiting exchange traded funds, such as the SPDR S&P Pharmaceuticals ETF (NYSEArca: XPH) and...